Submission Of New Drug Application For Acute Myeloid Leukemia Treatment "Olutasidenib" In Japan
27/05/2026 07:38
BRIEF-Kissei Pharmaceutical Co Ltd - Submission Of New Drug Application For Acute Myeloid Leukemia Treatment "Olutasidenib" In Japan May 27 (Reuters) - Kissei Pharmaceutical Co Ltd 4547.T:
KISSEI PHARMACEUTICAL CO LTD: SUBMISSION OF NEW DRUG APPLICATION FOR ACUTE MYELOID LEUKEMIA TREATMENT "OLUTASIDENIB" IN JAPAN
Source text: ID:nTSqa8652a
Further company coverage: 4547.T
(Reporting by Tokyo Newsroom)
((+81345201189;))